Bistacrine derivatives as new potent antimalarials

Area of Science:

• Medicinal Chemistry
• Parasitology
• Drug Discovery

Background:

• Tacrine derivatives are investigated for antimalarial properties.
• Linking two tacrine molecules enhances antimalarial activity.
• Structure-activity relationships are crucial for optimizing drug candidates.

Purpose of the Study:

• To synthesize and evaluate monomeric and dimeric tacrine derivatives as antimalarial agents.
• To establish structure-activity relationships for novel antimalarial compounds.
• To identify potent and safe drug candidates targeting Plasmodium parasites.

Main Methods:

• Synthesis of a library of monomeric and dimeric tacrine derivatives.
• In vitro testing against chloroquine-sensitive (3D7) and chloroquine-resistant (Dd2) Plasmodium strains.
• Determination of IC50 values and cytotoxicity assessments.
• Target identification, focusing on the cysteine protease falcipain-2.

Main Results:

• Dimeric tacrine derivatives demonstrated significantly increased antimalarial activity compared to monomers.
• The most active compounds achieved IC50 values in the nanomolar range.
• Compounds exhibited low cytotoxicity against host cells.
• The identified compounds target falcipain-2, a key enzyme for Plasmodium survival.

Conclusions:

• Linking tacrine molecules is a promising strategy for developing potent antimalarial drugs.
• The synthesized tacrine derivatives represent potential lead compounds for malaria treatment.
• Targeting falcipain-2 with novel tacrine derivatives offers a viable therapeutic approach against malaria.